Steroid therapy as an environmental factor in asthmatic patients: Drifting towards COPD

A. Pukhalsky, G. Shmariba, K. Zykov, V. Alioshkin (Moscow, Russian Federation)

Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Session: Clinical aspects and treatment of asthma and allergic respiratory diseases
Session type: Thematic Poster Session
Number: 4661
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Pukhalsky, G. Shmariba, K. Zykov, V. Alioshkin (Moscow, Russian Federation). Steroid therapy as an environmental factor in asthmatic patients: Drifting towards COPD. Eur Respir J 2010; 36: Suppl. 54, 4661

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020


The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Noncompliance factors in Russian asthma and COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 274s
Year: 2005

Characteristics of asthma patients responding to anti-IgE therapy
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Adhesion to inhaled treatment in patients with asthma and COPD
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014



Sexuality in patients with asthma and/or COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 54s
Year: 2003

YS5: The influence of glucocorticoid therapy on trancription factor balance in asthma patients
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016


Obesity and the response to inhaled budesonide in patients with asthma
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007


COPD exacerbations: is eosinophilia a protective factor?
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Inhaled corticosteroid related pneumonia in real world among the patients with asthma and COPD
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Pharmacogenetics of inhaled corticosteroid response in adults with asthma
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020